- Home
- EVOK vs STRR Comparison
EVOK vs STRR Comparison
Compare EVOK & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- STRR
- Stock Information
- Founded
- EVOK 2007
- STRR 1985
- Country
- EVOK United States
- STRR United States
- Employees
- EVOK N/A
- STRR N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EVOK Health Care
- STRR Health Care
- Exchange
- EVOK Nasdaq
- STRR Nasdaq
- Market Cap
- EVOK 4.2M
- STRR 6.3M
- IPO Year
- EVOK 2013
- STRR N/A
- Fundamental
- Price
- EVOK $6.09
- STRR $1.95
- Analyst Decision
- EVOK
- STRR Strong Buy
- Analyst Count
- EVOK 0
- STRR 1
- Target Price
- EVOK N/A
- STRR $5.00
- AVG Volume (30 Days)
- EVOK 7.2M
- STRR 9.1K
- Earning Date
- EVOK 08-12-2025
- STRR 08-12-2025
- Dividend Yield
- EVOK N/A
- STRR N/A
- EPS Growth
- EVOK N/A
- STRR N/A
- EPS
- EVOK N/A
- STRR N/A
- Revenue
- EVOK $11,594,083.00
- STRR $57,165,000.00
- Revenue This Year
- EVOK $57.82
- STRR $33.64
- Revenue Next Year
- EVOK $59.12
- STRR $22.87
- P/E Ratio
- EVOK N/A
- STRR N/A
- Revenue Growth
- EVOK 89.89
- STRR 34.33
- 52 Week Low
- EVOK $1.94
- STRR $1.72
- 52 Week High
- EVOK $12.32
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- EVOK 74.84
- STRR 43.68
- Support Level
- EVOK $2.52
- STRR $1.94
- Resistance Level
- EVOK $9.88
- STRR $2.00
- Average True Range (ATR)
- EVOK 0.49
- STRR 0.05
- MACD
- EVOK 0.39
- STRR 0.00
- Stochastic Oscillator
- EVOK 49.19
- STRR 16.67
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.